Tag: M&A

BMS Selling $19bn of Bonds to Buy Celgene

The U.S. drugmaker Bristol-Myers Squibb (BMS) is preparing to place $19 billion in bonds to fund the acquisition of the rival company Celgene Corp in the largest bond issue since the beginning of 2019...

Amgen Agreed to Buy Danish Biotech Nuevolution

amgen
Amgen has agreed to buy Danish biotech Nuevolution for 1.61bn krona ($167m), three years after forging a drug discovery alliance with the company. The board of Copenhagen-based, Sweden-listed Nuevo...

Evotec Announced Acquisition of Just Biotherapeutics

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc., for up to $ 90 m including potential performance-based earn-out components expecte...

Merck to Acquire Peloton Therapeutics

Merck, known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. today announced that the companies have entered into a definitive agreement under which Merck, through a subsid...

Catalent Announced Acquisition of US-based Paragon

Catalent has wrapped up its $1.2bn acquisition of Maryland-based gene therapy contract development and manufacturing organisation (CDMO) Paragon Bioservices. The all-cash deal between Catalent ...

EVER Pharma Completed Amneal Deutschland Acquisition

EVER Pharma Holding Ges.m.b.H (Austria) announced that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operat...

ESSA Pharma to Acquire Realm Therapeutics

ESSA Pharma Inc. announced today that it has entered into a definitive  agreement with Realm Therapeutics plc setting forth the terms of an acquisition whereby ESSA will acquire all of the issued and ...

3M Buy Medical Device Maker Acelity

3M Co. agreed to buy medical-products maker Acelity Inc. for about $4.4 billion, its biggest acquisition ever, as new Chief Executive Officer Mike Roman takes a more aggressive approach to expanding t...

Roche Spins Out New Biotech Nimble Therapeutics

Roche has spun out Nimble Therapeutics, a new biotech that starts life with $10 million in financing and chemical synthesis technology developed at Roche, along with the team that helped create it. Fi...

Pfizer Agreed to Acquire Clinical-Stage Biotech Therachon

pfizer
Pfizer today announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare diseases...

Novartis Agreed to Pay $3.4 billion for Eye Drug Assets

Novartis AG agreed to pay $3.4 billion for eye-disease medicines that Takeda Pharmaceutical Co. is selling to shed debt after its $62 billion acquisition of Shire Plc. The main product in the deal ...

Merck to Buy Intermolecular

Merck, a leading science and technology company, has signed a definitive agreement to acquire Intermolecular Inc. through a subsidiary for $1.20 per share in an all cash transaction, representing an e...

WuXi AppTec Acquires Pharmapace

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced that it has acquired Pharmapace, Inc., a US-based clinical research se...

Lundbeck Signed $400m Agreement to Acquire Abide Therapeutics

Danish pharmaceutical company Lundbeck has signed a $400m definitive agreement to acquire US-based Abide Therapeutics. The deal involves an upfront payment of $250m and up to $150m in potential dev...

Blackstone Group Announced 46 per cent stake Purchase in Geo-Young

Blackstone Group, the world’s largest manager of alternative assets, announced that it has agreed to acquire a 46 per cent stake in Geo-Young, South Korea’s top drug retailer. The New York-based PE...

Roche Announced Another Extension of its $4.3 billion Offer for Spark

Roche on Friday  announced another extension of its $4.3 billion offer for gene therapy specialist Spark Therapeutics, this time until June 3, saying a review by U.S. authorities is taking longer than...